Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management | Covered with prior authorization |
| Cardiovascular risk reduction (SELECT indication) | Covered with prior authorization |
If your plan denies coverage, two cash programs to check.
- Strut Health$149 a month, with auto-refillcompounded semaglutide, not FDA-approvedCheck price →
- Shed$199 a monthcompounded semaglutide, not FDA-approvedCheck price →
Prior authorization: the plan reviews the prescription before it pays.
Premera covers Wegovy once the plan signs off. But it only covers it where your employer bought the weight-loss drug benefit. This answer covers Commercial plans and Medicare Advantage.
Source: Premera Blue Cross policy 5.01.621. Checked June 12, 2026.
Where your plan lists it. Premera's Essentials E4 drug list, effective September 1, 2026, puts Wegovy on tier 4, the non-preferred tier on that four-tier list, with prior authorization and a limit of 4 pens per 28 days. Every Wegovy row also carries the OPT flag. Premera's key says many benefit plans exclude weight management drugs. Source: Premera Blue Cross Essentials (E1/E4) Formulary Drug List. Checked September 6, 2026.
What it costs once they say yes. With commercial insurance the manufacturer savings card takes Wegovy to as little as $25 a month. Your plan sets the copay before the card applies. What Wegovy costs with your plan.
This varies by plan. At Premera, the weight-loss drug benefit is something the employer has to buy. It is not there by default. A large share of Premera commercial members have no coverage for GLP-1s used in obesity, whatever their BMI. Express Scripts runs the drug benefit for most Premera commercial plans.
Coverage by indication
| BMI threshold | BMI 30 or higher. BMI 27 or higher also qualifies with a comorbidity, per the criteria in policy 5.01.621 |
| Step therapy | Some plan designs make you try phentermine or orlistat first. Six months of a documented lifestyle program is required. |
What the prior authorization needs:
- Your employer group has to have bought the weight-loss drug benefit. A base plan does not carry it
- Prior authorization is required on all qualifying plans
- Six months of a documented lifestyle program
- Updated quantity limits took effect January 1, 2026
Source: Premera Blue Cross policy 5.01.621. Premera's own medical policy PDF, public URL confirmed, binary file, policy number confirmed from the search-result title. Lower confidence: the policy file would not open at the payer's own address, so the policy number and rules were checked against a second source.
| BMI threshold | BMI 27 or higher, with established cardiovascular disease |
| Cardiovascular criteria | Established cardiovascular disease on the record, judged by the criteria used to enroll the SELECT trial |
| Step therapy | Wegovy is not on the drug list for most plans, so a request goes through the standard formulary exception process. |
What the prior authorization needs:
- Formulary exception request through the standard process
- On Medicare Advantage, CMS policy allows coverage where there is a medically accepted indication beyond weight loss
Source: Premera Providers, Wegovy Coverage with the New Cardiovascular Indication. Premera's own provider news page.
Ozempic, Mounjaro and Rybelsus on Premera Blue Cross plans
Ozempic, Mounjaro and Rybelsus are approved for type 2 diabetes, not weight loss.
Does Premera cover Ozempic?
Yes, with prior approval. Premera pays for Ozempic once your prescriber gets the plan to sign off.
Premera Blue Cross covers Ozempic for type 2 diabetes once the plan signs off. You have to be 18 or older, with a type 2 diabetes diagnosis. You also need an adequate trial of metformin, or a contraindication to it. A quantity limit holds you to the FDA-approved maximum daily dose. Premera does not cover Ozempic for weight loss, and it calls that use investigational. The weight-loss form of semaglutide is Wegovy. Premera reviews Wegovy under a separate weight-management policy, and that one only applies where the employer group bought weight-loss drug coverage.
Checked August 27, 2026.
What Premera requires for Ozempic
| Step therapy | Required |
What the prior authorization needs:
- Aged 18 years or older
- Has been diagnosed with type 2 diabetes
- Has had an adequate trial of metformin, or a contraindication to it
- Will not be used in combination with another GLP-1 or GIP/GLP-1 receptor agonist
- Does not exceed the FDA-approved maximum daily dose (quantity limit applies to all strengths)
Source: Premera policy 5.01.569. The plan's own coverage policy.
Recent change: Policy 5.01.569 was last revised on June 22, 2026, and took effect on July 1, 2026. That revision added an age rule, 18 years or older, to the first-line GLP-1 criteria that include Ozempic.
Does Premera cover Mounjaro?
Yes, with prior approval. Premera pays for Mounjaro once your prescriber gets the plan to sign off.
Premera covers Mounjaro for type 2 diabetes once the plan signs off. Pharmacy policy 5.01.569, in force from July 1, 2026, sets the rules. It calls Mounjaro medically necessary for adults, and for children aged 10 or older, who have a type 2 diabetes diagnosis. They also need an adequate trial of metformin, or a contraindication to it. It cannot be taken with another GLP-1 or GIP/GLP-1 drug. Premera does not cover Mounjaro for weight loss, and it calls that use investigational. Zepbound is the tirzepatide for weight loss, and it runs under a separate policy, 5.01.621.
Checked August 27, 2026.
What Premera requires for Mounjaro
| Step therapy | Required |
What the prior authorization needs:
- Aged 10 years or older
- Documented type 2 diabetes diagnosis
- An adequate trial of metformin, or a contraindication to it
- Not used in combination with another GLP-1 or GIP/GLP-1 receptor agonist
- Dose does not exceed the FDA-labeled maximum daily dose
Source: Premera policy 5.01.569. The plan's own coverage policy.
Recent change: Policy 5.01.569 was last revised on June 22, 2026, and it took effect on July 1, 2026. It sets a minimum age of 10 for Mounjaro.
Does Premera cover Rybelsus?
Yes, with prior approval. Premera pays for Rybelsus once your prescriber gets the plan to sign off.
Premera Blue Cross covers Rybelsus for type 2 diabetes once the plan signs off. Pharmacy policy 5.01.569, in force from July 1, 2026, sets the rules. It treats Rybelsus as a first-line GLP-1. It calls the drug medically necessary for adults aged 18 or older who have a type 2 diabetes diagnosis. They also need an adequate trial of metformin, or a contraindication to it. It cannot be taken with another GLP-1 or GIP/GLP-1 drug. The FDA approved Rybelsus for type 2 diabetes only, so Premera does not cover it for weight loss. Wegovy is the semaglutide for weight loss. Premera reviews Wegovy under a separate policy, 5.01.621, and that one only applies where the employer group bought weight-management drug coverage.
Checked August 28, 2026.
What Premera requires for Rybelsus
| Step therapy | Required |
What the prior authorization needs:
- Aged 18 years or older
- Has been diagnosed with type 2 diabetes
- Has had an adequate trial of metformin, or a contraindication to it
- Will not be used in combination with another GLP-1 or GIP/GLP-1 receptor agonist
- Does not exceed the FDA-approved maximum daily dose (quantity limit of 30 tablets per 30 days applies to all strengths)
Source: Premera policy 5.01.569. The plan's own coverage policy.
Recent change: Policy 5.01.569 was last revised on June 22, 2026, and it took effect on July 1, 2026. The annual review of May 1, 2026 added a minimum age of 18 to the first-line GLP-1 criteria that include Rybelsus. An update on January 1, 2026 added a quantity limit of 30 tablets per 30 days, and that limit applies to every Rybelsus strength.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Start with the Premera Blue Cross prior-authorization letter template, which cites this plan's policy and the diagnosis codes a reviewer looks for. Pick the indication that matches your clinical picture.
- Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
- Your plan may treat another GLP-1 differently. The Premera Blue Cross coverage check lists all 4, with the source for each.
- If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Premera Blue Cross cover Wegovy?
Yes on some plans. Premera covers Wegovy once the plan signs off. But it only covers it where your employer bought the weight-loss drug benefit. Policy checked June 2026.
What does Premera Blue Cross require to approve Wegovy?
For obesity / chronic weight management: The BMI requirement is BMI 30 or higher. BMI 27 or higher also qualifies with a comorbidity, per the criteria in policy 5.01.621. Some plan designs make you try phentermine or orlistat first. Six months of a documented lifestyle program is required.
Why might Premera Blue Cross deny Wegovy even if I meet the criteria?
At Premera, the weight-loss drug benefit is something the employer has to buy. It is not there by default. A large share of Premera commercial members have no coverage for GLP-1s used in obesity, whatever their BMI. Express Scripts runs the drug benefit for most Premera commercial plans.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.